Company Filing History:

8 out of 1,008

Bayer Corporation

patents

1 out of 832,680

Other

patents

Years Active: 1998-2000

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6166082 - Substituted 5-biarylpentanoic acids and derivatives as matrix (2000-12-26),

2. 5886043 - Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease (1999-03-23),

3. 5886022 - Substituted cycloalkanecarboxylic acid derivatives as matrix (1999-03-23),

4. 5874473 - Substituted cycloalkanecarboxylic acid derivatives as matrix (1999-02-23),

5. 5861428 - Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease (1999-01-19),

6. 5861427 - Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease (1999-01-19),

7. 5859047 - Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease (1999-01-12),

8. 5854277 - Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors (1998-12-29),

9. 5789434 - Derivatives of substituted 4-biarylbutyric acid as matrix (1998-08-04),

Title: Scott McClelland Wilhelm: Innovator in Pharmaceutical Compositions

Introduction

Scott McClelland Wilhelm is a notable inventor based in Orange, Connecticut, with a significant contribution to the field of pharmaceuticals. He holds a total of nine patents, showcasing his innovative approach to developing new compounds and treatments. His work primarily focuses on matrix metalloproteases and their inhibitors, which play a crucial role in various physiological conditions.

Latest Patents

Wilhelm's latest patents include "Substituted 5-biarylpentanoic acids and derivatives as matrix - Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions." This invention features compounds with a generalized formula that includes substituted cycloalkanecarboxylic acid derivatives. These compounds are designed to inhibit matrix metalloproteases, offering potential therapeutic benefits for various health issues.

Career Highlights

Throughout his career, Scott McClelland Wilhelm has worked with prominent companies, including Bayer Corporation. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health challenges. His dedication to research and development has led to significant advancements in the field.

Collaborations

Wilhelm has collaborated with notable professionals in his field, including Harold C. Kluender and Brian R. Dixon. These partnerships have contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Scott McClelland Wilhelm is a distinguished inventor whose work in pharmaceutical compositions has made a lasting impact. His innovative patents and collaborations highlight his commitment to improving health outcomes through scientific research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.